Skip to main content
Clinical Trials/CTRI/2022/06/042980
CTRI/2022/06/042980CompletedNot Applicable

Medication adherence and management of risk factors for secondary prevention of stroke using smart phone- based application: A feasibility study

World Stroke Organization1 site in 1 country192 target enrollmentStarted: October 6, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
192
Locations
1
Primary Endpoint
1. Medication adherence is defined as consumption of at least more than 80% of their medications for the last two weeks based on the last prescription.

Study Overview

Brief Summary

This study aims to develop a smart phone based personal monitoring app among stroke survivors to improve adherence to the medication, control of vascular risk factors, provide health education and physician involvement. Phase 1 of the study will be development of mobile app using Qualitative -Delphi method and phase 2 will be a randomized controlled trial designed to determine the feasibility of using this app in hospital setting for secondary stroke prevention. One hundred and ninety-two (n=192) adult patients with onset of stroke within 1 month will be randomized into intervention and control arm. The primary outcome will be assessed as medication adherence and control of vascular risk factors. The secondary outcome will be Vascular events namely TIA/Stroke/Cardiac events/Vascular deaths, functional outcome which will be assessed by mRS. The follow up will be done at the baseline, 3 month and 6 month. The data will be analyzed using appropriate statistical measures to determine efficacy of the mobile app in secondary prevention of stroke.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Open Label

Eligibility Criteria

Ages
18.00 Year(s) to 80.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Adult (>18 years) patients with onset of stroke within 1 month.
  • •2.Severity :- mRs<5 3.Presence of one or more vascular risk factors such as hypertension, diabetes mellitus, smoking and dyslipidemia.
  • •4.Patient/caregivers who could fully understand the use of an Android-based smartphone.

Exclusion Criteria

  • •1.Patients with severe disability -modified Rankin Scale score>4 2.Patients who do not consent.
  • •3.Severe cognitive impairment.
  • •4.Stroke survivor without a primary caregiver.

Outcomes

Primary Outcomes

1. Medication adherence is defined as consumption of at least more than 80% of their medications for the last two weeks based on the last prescription.

Time Frame: Baseline, Three months and Six months

2. Control of vascular risk factors

Time Frame: Baseline, Three months and Six months

Secondary Outcomes

  • 1. Vascularevents-TIA/Stroke/Cardiac events/Vascular deaths(2. Functional outcome-assessed by mRS)

Investigators

Sponsor
World Stroke Organization
Sponsor Class
Other [organization]

Study Sites (1)

Loading locations...

Similar Trials